Dr. Reddy's Laboratories launches Doxycycline Capsules

03 May 2024 Evaluate

Dr. Reddy's Laboratories has launched Doxycycline Capsules, 40 mg in the U.S. market, a therapeutic generic equivalent of ORACEA (doxycycline, USP) Capsules, 40 mg approved by the U.S. Food and Drug Administration (USFDA). Dr. Reddy’s Doxycycline Capsules, 40 mg, are supplied in bottle counts of 30. 

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.


Dr. Reddys Lab Share Price

1268.25 -0.35 (-0.03%)
30-Dec-2025 11:23 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1716.40
Dr. Reddys Lab 1268.25
Cipla 1487.35
Zydus Lifesciences 902.25
Lupin 2079.50
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×